Updated Announcement

Shift of conference to July 2022 due to COVID situation!

22nd Drug Design & Development Seminar (DDDS) 2022 of the
German Society for Parasitology (DGP)

"TransAlp Conference on Human and Animal Parasitic Diseases"

Date: July 12th - 15th, 2022

Venue: Deutsches Museum - Flugwerft Schleißheim
Effnerstraße 18
85764 Oberschleißheim / Munich, Germany

We plan an in-person event as the best option for scientific exchange and interaction.
We will carefully monitor the pandemic situation. In case heath concerns or restrictions hinder us to conduct a live event safely, registration fees will be reimbursed.

Organizers: University of Bern, DNDi & LMU Munich

On the occasion of the 22nd DDDS conference you are cordially invited to participate and to present your research in an oral presentation (15 minutes) or as poster. An abstract is requested for both talks and posters
(abstract guidelines below). The scientific board will select the topics for oral presentations or posters depending on the abstracts. Renowned international keynote speakers will provide a high-quality scientific framework.
The seminar will be opened with a welcome reception on Tuesday evening and conclude Friday at noon.

Deadline extension for registration is April 4th, 2022
Deadline extension for abstract submission is April 26th, 2022

About the Drug Design & Development Seminar (DDDS)

The Drug Design & Development Seminar (DDDS) was founded in 1999 as an active working group of the German Society for Parasitology, by Prof. Dr. Peter Köhler (Univ. of Zürich, CH), Prof. Dr. Rolf Walter (BNI, Hamburg, DE), and Prof. Dr. Heiner Schirmer (Univ. of Heidelberg, DE). Since 2004 Prof. Dr. Paul M. Selzer (Boehringer Ingelheim Animal Health, Ingelheim, DE) is the coordinator of the DDDS transferring the meeting into an international well recognized scientific forum. Exchange of scientific information about anti-parasitic chemotherapy between universities, industry, and other research organizations continues to be important to accelerate anti-parasitic drug development. The DDDS is open to all scientists and professionals interested in the field of anti-parasitic research. The DDDS aims at connecting human and veterinary health by complementary approaches in medical and veterinary parasitology and medicinal chemistry to aim and stimulate One-Health approaches to combat parasitic diseases. The main topics include but are not limited to:
- Target identification, characterization, and validation
- Identification of compounds
- Synthesis and optimization of lead compounds towards marketable drugs
- Testing active compounds in animal models